SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(RULE 13D-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(A)
VIRAGEN, INC.
--------------------------------------------------------------------------------
(NAME OF ISSUER)
COMMON STOCK, $0.001 PAR VALUE PER SHARE
--------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
212066 10-4
--------------------------------------------------------------------------------
(CUSIP NUMBER)
NEIL BERMAN, 21346 ST ANDREWS BLVD #421, BOCA RATON, FL, 33433, (561)866-4567
DOUGLAS CALDER OR VIRAGEN, 865 SW 78TH AVE., SUITE 100, BOCA RATON, FL, 33433
(954)233-8746
--------------------------------------------------------------------------------
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND
COMMUNICATIONS)
MARCH 23, 2007
-------------------------------------------------------
(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)
IF THE FILING PERSON HAS PREVIOUSLY FILED A STATEMENT ON SCHEDULE 13G TO REPORT
THE ACQUISITION WHICH IS THE SUBJECT OF THIS SCHEDULE 13D, AND IS FILING THIS
SCHEDULE BECAUSE OF RULE 13D-1(E), 13D-1(F) OR 13D-1(G), CHECK THE FOLLOWING BOX
|_|.
NOTE: SCHEDULES FILED IN PAPER FORMAT SHALL INCLUDE A SIGNED ORIGINAL AND FIVE
COPIES OF THE SCHEDULE, INCLUDING ALL EXHIBITS. SEE RULE 13D-7 FOR OTHER PARTIES
TO WHOM COPIES ARE TO BE SENT.
* THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING PERSON'S
INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF SECURITIES, AND
FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH WOULD ALTER
DISCLOSURES PROVIDED IN A PRIOR COVER PAGE.
THE INFORMATION REQUIRED ON THE REMAINDER OF THIS COVER PAGE SHALL NOT BE DEEMED
TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF
1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT SECTION OF THE ACT
BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT (HOWEVER, SEE THE
NOTES).
SCHEDULE 13D
CUSIP NO
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
NEIL BERMAN 262-80-2875
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) |_|
(B) |_|
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS (SEE INSTRUCTIONS)
PRIVATE FUNDS INDIVIDUAL
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(D) OR 2(E) |_|
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY 19,100,879
OWNED BY EACH SHARES ALL PURCHASED THROUGH OPEN MARKET PURCHASES
REPORTING PERSON IN CASH ACCOUNTS FROM 3/21/2007 UNTIL 5/2/2007 AT
WITH PRICES RANGING FROM $0.0202 TO $0.094
---------------------------------------------------------
(8) SHARED VOTING POWER
19,100,879
---------------------------------------------------------
(9) SOLE DISPOSITIVE POWER
---------------------------------------------------------
(10) SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8.91%
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) |_|
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.91%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
--------------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER.
VIRAGEN, INC.
865 S.W. 78TH AVENUE, SUUITE 100
PLANTATION, FLORIDA 33324
ITEM 2. IDENTITY AND BACKGROUND.
TAX 10 59-2101668 / SEC COMMISSION # 001-15823
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
CASH ACCOUNTS
PERSONAL FUNDS
ITEM 4. PURPOSE OF TRANSACTION.
INVESTMENT AND TRADING
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
INDIVIDUAL INVESTOR
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS, OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
NONE.
ITEM 7. MATERIALS TO BE FILED AS EXHIBITS.
NONE.
214,360,131 The percentages used herein are calculated based upon
the 214,360,131 shres of Common Stock issued and outstanding as of March 19,
2007 as described in the Issurers Form 8-K filed on March 22, 2007.
SIGNATURE
AFTER REASONABLE INQUIRY AND TO THE BEST OF MY KNOWLEDGE AND BELIEF,
I CERTIFY THAT THE INFORMATION SET FORTH IN THIS STATEMENT IS TRUE, COMPLETE AND
CORRECT.
DATED: MAY 2, 2007 BY: /S/ NEIL BERMAN
------------------------
NEIL BERMAN